SCHEMBL6165037

SCHEMBL6165037

N#CCCn1nc(Cc2ccccc2)c2c1CCC2=O

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOB P27338 6/20 0.42
TSHR P16473 4/20 0.37
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
GAA P10253 1/20 0.35
CYP1A2 P05177 2/20 0.35
GLA P06280 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
MAPT P10636 1/20 0.34
ALOX15 P16050 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CASP1 P29466 1/20 0.34
CYP2C19 P33261 1/20 0.34
CASP7 P55210 1/20 0.34
HIF1A Q16665 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164117 0.84 HTT (0.46) TSHRKMT2AMEN1CYP1A2MAPT
SCHEMBL6162649 0.81 PARP1 (0.37) MAOBTSHRKMT2AMEN1GAA
SCHEMBL6166686 0.74 MAOB (0.33) MAOBTSHRKMT2AGAACYP1A2
SCHEMBL6166684 0.74 MAOB (0.33) MAOBTSHRKMT2AGAACYP1A2
SCHEMBL6165983 0.74 ATM (0.44) MAOBTSHRKMT2AGAACYP1A2
SCHEMBL6167954 0.72 HTT (0.32)
SCHEMBL6165490 0.72 LMNA (0.49) TSHRKMT2AMEN1GAACYP1A2
SCHEMBL6167036 0.72 RIPK3 (0.39) MAOBKMT2AMAPTALDH1A1
SCHEMBL6166254 0.71 ALDH1A1 (0.38) MAOBTSHRKMT2AMEN1GAA
SCHEMBL6164339 0.71 HTT (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed